Author | Number of patients | Quality score | Duration (months) | ITT or PP | Symptom score | Max urinary flow rate (mL/s) | Prostate volume (cm3) |
---|---|---|---|---|---|---|---|
McConnell et al, 1998 PLESS | 3040 | 4 | 48 | PP | ++ | ++ | ++ |
Marbergher et al, 1998 PROWESS | 2902 | 5 | 24 | PP | ++ | ++ | ++ |
Byrnes et al, 1995 | 2417 | 3 | 12 | ITT | + | No data | Â |
Tenover et al, 1997 | 2112 | 3 | 12 | PP | ++ | No data | Â |
Andersen et al, 1995 | 707 | 3 | 24 | PP | ++ | ++ | ++ |
Lepor et al, 1996 VA cooperative study. | 615 | 4 | 12 | PP | - | - | ++ |
Nickel et al, 1996 PROSPECT | 613 | 5 | 24 | ITT | ++ | ++ | ++ |
Gormley et al, 1992 North American study | 598 | 3 | 12 | ITT | ++ | ++ | ++ |
Finasteride study group, 1993 International study | 501 | 3 | 12 | PP | ++ | + | ++ |
Beisland et al, 1992 | 182 | 3 | 6 | ITT | + | + | ++ |
Abrams et al, 1999 | 121 | 3 | 12 | PP | - | + | ++ |
Kirby et al, 1992 | 50 | 4 | 3 | PP | ++ | ++ | - |
Yu et al, 1995 | 50 | 3 | 6 | PP | + | + | + |
Marks et al, 1997 | 41 | 4 | 6 | PP | - | - | ++ |
Tammela & Kontturi, 1993 | 36 | 3 | 6 | ITT | No data | - | ++ |
Studies with finasteride plus additional interventions | |||||||
Lukkarinen et al, 1999 | 61 | 3 | 24 | PP | - | - | ++ |
Isotalo et al, 2001 | 55 | 4 | 18 | ITT | - | + | ++ |